论文部分内容阅读
目的:分析溶栓治疗急性ST段抬高型心肌梗死(STEMI)在基层医院的应用价值。方法:收集2014年1月-2015年12月本院接收的STEMI患者72例为研究对象,将其随机分为对照组与观察组,对照组给予常规治疗,在常规治疗基础上观察组给予尿激酶溶栓治疗,对比分析两组患者血管再通率、不良反应发生率及病死率。结果:观察组6 h再通率、总再通率高于对照组,30 d病死率及不良反应发生率低于对照组,组间比较,差异具有统计学意义(P<0.05)。结论:基层医院STEMI患者接受尿激酶溶栓治疗的临床疗效理想。
Objective: To analyze the value of thrombolysis in the treatment of acute ST-segment elevation myocardial infarction (STEMI) in primary hospitals. Methods: Seventy-two patients with STEMI received in our hospital from January 2014 to December 2015 were selected and randomly divided into control group and observation group. The control group was given routine treatment. On the basis of routine treatment, the observation group was given urine Keto thrombolytic therapy, comparative analysis of two groups of patients with recanalization rate, the incidence of adverse reactions and mortality. Results: The 6 h recanalization rate and the total recanalization rate in the observation group were higher than those in the control group. The mortality at 30 d and the incidence of adverse reactions were lower than those in the control group. There was significant difference between the two groups (P <0.05). Conclusion: The primary clinical STEMI patients receiving urokinase thrombolytic therapy clinical efficacy.